LivaNova PLC Ordinary Shares (LIVN) is a publicly traded Healthcare sector company. As of May 21, 2026, LIVN trades at $73.56 with a market cap of $3.97B and a P/E ratio of -16.53. LIVN moved +1.08% today. Year to date, LIVN is +16.57%; over the trailing twelve months it is +64.24%. Its 52-week range spans $32.48 to $74.32. Analyst consensus is buy with an average price target of $80.00. Rallies surfaces LIVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
LivaNova Beats Q1 with $0.98 EPS, Raises 2026 Revenue Growth to 8%: LivaNova posted Q1 adjusted EPS of $0.98 beating estimates by $0.08 and revenue of $362.3 million, up 14.3% year-over-year. The company raised its full-year 2026 revenue growth guidance to 7.0%-8.0% CC and EPS outlook to $4.20-$4.30, though shares fell over 2% premarket.
| Metric | Value |
|---|---|
| Price | $73.56 |
| Market Cap | $3.97B |
| P/E Ratio | -16.53 |
| EPS | $-4.45 |
| Dividend Yield | 0.00% |
| 52-Week High | $74.32 |
| 52-Week Low | $32.48 |
| Volume | 246 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.39B |
| Net Income | $-242.47M |
| Gross Margin | 67.71% |
7 analysts cover LIVN: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $80.00.